| Latest findings on the diabetes epidemic states that around 18 million of Americans are suffering from full-blown diabetes. Further, since diabetes causes damage to other parts of the body such as the nervous system and the skeletal system, these patients often have to be treated with drugs like musculoskeletal system drugs, or they might in addition opt for herbal supplements such as ALA (alpha-lipoic acid) and GLA (gamma-lipoic acid), which may function to help diabetic neuropathy and reduce pain. Growing number of diabetic cases have resulted into the expansion of anti diabetic drugs market in the recent years. The anti-diabetic medicines is one of the leading therapeutic sectors of the worldwide pharmaceutical sales and in the last few years it has grown with the average growth rate of around 20 percent annually. Currently, anti diabetic medicines market sizes around US $ 17 billion that is predicted to cross US $ 22 billion by the end of 2012. Anti diabetic medication is used for controlling blood sugar levels can be grouped into six major segments that are insulin, biguanides, sufornylureas, meglitinides, thiazolidinediones, and alpha-glucosidase inhibitors. Of these six, insulin sector occupies topmost position in whole of the anti diabetic drugs market with a share of 37.5% followed by thiazolidinediones group. These medications when taken into right quantity would help in curtailing the risks of risk of serious complications that can arise from diabetes mellitus, a disorder of metabolism.